172 related articles for article (PubMed ID: 28744792)
21. Association Between Adrenal-Restrictive HSD3B1 Inheritance and Hormone-Independent Subtypes of Endometrial and Breast Cancer.
McManus JM; Vargas R; Bazeley PS; Schumacher FR; Sharifi N
JNCI Cancer Spectr; 2022 Sep; 6(5):. PubMed ID: 35947687
[TBL] [Abstract][Full Text] [Related]
22. Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer.
Kruse ML; Patel M; McManus J; Chung YM; Li X; Wei W; Bazeley PS; Nakamura F; Hardaway A; Downs E; Chandarlapaty S; Thomas M; Moore HC; Budd GT; Tang WHW; Hazen SL; Bernstein A; Nik-Zainal S; Abraham J; Sharifi N
JCI Insight; 2021 Oct; 6(20):. PubMed ID: 34520399
[TBL] [Abstract][Full Text] [Related]
23. Association of HSD3B1 Genotype and Clinical Outcomes in Postmenopausal Estrogen-Receptor-Positive Breast Cancer.
Flanagan MR; Doody DR; Voutsinas J; Wu Q; Banda K; Sharifi N; Li CI; Gadi VK
Ann Surg Oncol; 2022 Oct; 29(11):7194-7201. PubMed ID: 35776258
[TBL] [Abstract][Full Text] [Related]
24. Nitrophenols suppress steroidogenesis in prehierarchical chicken ovarian follicles by targeting STAR, HSD3B1, and CYP19A1 and downregulating LH and estrogen receptor expression.
Sechman A; Grzegorzewska AK; Grzesiak M; Kozubek A; Katarzyńska-Banasik D; Kowalik K; Hrabia A
Domest Anim Endocrinol; 2020 Jan; 70():106378. PubMed ID: 31514021
[TBL] [Abstract][Full Text] [Related]
25. ER81-shRNA inhibits growth of triple-negative human breast cancer cell line MDA-MB-231 in vivo and in vitro.
Chen Y; Zou H; Yang LY; Li Y; Wang L; Hao Y; Yang JL
Asian Pac J Cancer Prev; 2012; 13(5):2385-92. PubMed ID: 22901226
[TBL] [Abstract][Full Text] [Related]
26. Germline HSD3B1 Genetics and Prostate Cancer Outcomes.
Thomas L; Sharifi N
Urology; 2020 Nov; 145():13-21. PubMed ID: 32866512
[TBL] [Abstract][Full Text] [Related]
27. The effect of orexin a on the StAR, CYP11A1 and HSD3B1 gene expression, as well as progesterone and androstenedione secretion in the porcine uterus during early pregnancy and the oestrous cycle.
Rytelewska E; Kisielewska K; Gudelska M; Kiezun M; Dobrzyn K; Bors K; Wyrebek J; Kaminska B; Kaminski T; Smolinska N
Theriogenology; 2020 Feb; 143():179-190. PubMed ID: 31733930
[TBL] [Abstract][Full Text] [Related]
28. Proximal GATA-binding sites are essential for human HSD3B1 gene transcription in the placenta.
Lai TC; Li HF; Li YS; Hung PY; Shyu MK; Hu MC
Sci Rep; 2017 Jun; 7(1):4271. PubMed ID: 28655875
[TBL] [Abstract][Full Text] [Related]
29. Differences in substrate and inhibitor kinetics of human type 1 and type 2 3beta-hydroxysteroid dehydrogenase are explained by the type 1 mutant, H156Y.
Thomas JL; Mason JI; Brandt S; Norris W
Endocr Res; 2002 Nov; 28(4):471-5. PubMed ID: 12530651
[TBL] [Abstract][Full Text] [Related]
30. Gossypol enantiomers potently inhibit human placental 3β-hydroxysteroid dehydrogenase 1 and aromatase activities.
Dong Y; Mao B; Li L; Guan H; Su Y; Li X; Lian Q; Huang P; Ge RS
Fitoterapia; 2016 Mar; 109():132-7. PubMed ID: 26709042
[TBL] [Abstract][Full Text] [Related]
31. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S
Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722
[TBL] [Abstract][Full Text] [Related]
32. Role of Cryptochrome-1 and Cryptochrome-2 in Aldosterone-Producing Adenomas and Adrenocortical Cells.
Tetti M; Castellano I; Venziano F; Magnino C; Veglio F; Mulatero P; Monticone S
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874863
[TBL] [Abstract][Full Text] [Related]
33. Structure, function and tissue-specific gene expression of 3β-hydroxysteroid dehydrogenase/5-ene-4-ene isomerase enzymes in classical and peripheral intracrine steroidogenic tissues.
Labrie F; Simard J; Luu-The V; Bélanger A; Pelletier G
J Steroid Biochem Mol Biol; 1992 Dec; 43(8):805-26. PubMed ID: 22217825
[TBL] [Abstract][Full Text] [Related]
34. Keratin 17 is overexpressed and predicts poor survival in estrogen receptor-negative/human epidermal growth factor receptor-2-negative breast cancer.
Merkin RD; Vanner EA; Romeiser JL; Shroyer ALW; Escobar-Hoyos LF; Li J; Powers RS; Burke S; Shroyer KR
Hum Pathol; 2017 Apr; 62():23-32. PubMed ID: 27816721
[TBL] [Abstract][Full Text] [Related]
35. Activity and inhibition of 3-beta-hydroxysteroid dehydrogenase/delta-5-4-isomerase in human skin.
Tóth I; Szécsi M; Julesz J; Faredin I
Skin Pharmacol; 1997; 10(3):160-8. PubMed ID: 9287397
[TBL] [Abstract][Full Text] [Related]
36. Immunolocalization of thymidylate synthase as a favorable prognostic marker in estrogen receptor-positive breast carcinoma.
Takagi K; Miki Y; Nakamura Y; Hirakawa H; Kakugawa Y; Amano G; Watanabe M; Ishida T; Sasano H; Suzuki T
Histol Histopathol; 2015 Oct; 30(10):1223-32. PubMed ID: 25873048
[TBL] [Abstract][Full Text] [Related]
37. Environmental mixture with estrogenic activity increases Hsd3b1 expression through estrogen receptors in immature rat granulosa cells.
Samardzija Nenadov D; Pogrmic-Majkic K; Fa S; Stanic B; Tubic A; Andric N
J Appl Toxicol; 2018 Jun; 38(6):879-887. PubMed ID: 29435998
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer.
Stangl-Kremser J; Lemberger U; Hassler MR; Bruchbacher A; Ilijazi D; Garstka N; Kramer G; Haitel A; Abufaraj M; Shariat SF
Clin Genitourin Cancer; 2019 Oct; 17(5):389-394. PubMed ID: 31331867
[TBL] [Abstract][Full Text] [Related]
39. Possible role of the aromatase-independent steroid metabolism pathways in hormone responsive primary breast cancers.
Hanamura T; Niwa T; Gohno T; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2014 Jan; 143(1):69-80. PubMed ID: 24292869
[TBL] [Abstract][Full Text] [Related]
40. Altered expression of genes involved in progesterone biosynthesis, metabolism and action in endometrial cancer.
Sinreih M; Hevir N; Rižner TL
Chem Biol Interact; 2013 Feb; 202(1-3):210-7. PubMed ID: 23200943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
